Literature DB >> 3542203

MPTP: current concepts and controversies.

J W Langston, I Irwin.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 3542203

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  44 in total

Review 1.  Glial cell response: A pathogenic factor in Parkinson's disease.

Authors:  Du Chu Wu; Kim Tieu; Oren Cohen; Dong-Kug Choi; Miquel Vila; Vernice Jackson-Lewis; Peter Teismann; Serge Przedborski
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

Review 2.  MPTP as a mitochondrial neurotoxic model of Parkinson's disease.

Authors:  Serge Przedborski; Kim Tieu; Celine Perier; Miquel Vila
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

3.  BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices.

Authors:  H Jourdi; L Hamo; T Oka; A Seegan; M Baudry
Journal:  Neuropharmacology       Date:  2009-01-21       Impact factor: 5.250

4.  Neuropharmacology of dopamine receptors:: Implications in neuropsychiatric diseases.

Authors:  F I Tarazi
Journal:  J Sci Res Med Sci       Date:  2001-10

5.  Modifications of precentral cortex discharge and EMG activity in monkeys with MPTP-induced lesions of DA nigral neurons.

Authors:  D J Doudet; C Gross; M Arluison; B Bioulac
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

Review 6.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

7.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.

Authors:  S Przedborski; V Jackson-Lewis; R Yokoyama; T Shibata; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

8.  6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.

Authors:  D J Doudet; H Miyake; R T Finn; C A McLellan; T G Aigner; R Q Wan; H R Adams; R M Cohen
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

9.  The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.

Authors:  Wei Cui; Zaijun Zhang; Wenming Li; Shengquan Hu; Shinghung Mak; Huan Zhang; Renwen Han; Shuai Yuan; Sai Li; Fei Sa; Daping Xu; Zhixiu Lin; Zhong Zuo; Jianhui Rong; Edmond Dik-Lung Ma; Tony Chunglit Choi; Simon My Lee; Yifan Han
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

10.  Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.

Authors:  Xiaoming Hu; Dan Zhang; Hao Pang; W Michael Caudle; Yachen Li; Huiming Gao; Yuxin Liu; Li Qian; Belinda Wilson; Donato A Di Monte; Syed F Ali; Jing Zhang; Michelle L Block; Jau-Shyong Hong
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.